rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2001-4-3
|
pubmed:abstractText |
Radiation therapy (RT) restricted to the tumor bed, by means of an interstitial implant, and lasting 4 to 5 days after lumpectomy was prospectively evaluated in early-stage breast cancer patients treated with breast-conserving therapy (BCT). The goals of the study were to determine whether treatment time can be reduced and whether elective treatment of the entire breast is necessary.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0732-183X
|
pubmed:author |
pubmed-author:BaglanK LKL,
pubmed-author:BenitezPP,
pubmed-author:ChenP YPY,
pubmed-author:EdmundsonGG,
pubmed-author:FrazierR CRC,
pubmed-author:GoldsteinN SNS,
pubmed-author:HuangR RRR,
pubmed-author:KestinL LLL,
pubmed-author:MartinezAA,
pubmed-author:MitchellCC,
pubmed-author:ViciniF AFA
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1993-2001
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:11283132-Actuarial Analysis,
pubmed-meshheading:11283132-Aged,
pubmed-meshheading:11283132-Brachytherapy,
pubmed-meshheading:11283132-Breast Neoplasms,
pubmed-meshheading:11283132-Case-Control Studies,
pubmed-meshheading:11283132-Chemotherapy, Adjuvant,
pubmed-meshheading:11283132-Combined Modality Therapy,
pubmed-meshheading:11283132-Dose Fractionation,
pubmed-meshheading:11283132-Female,
pubmed-meshheading:11283132-Humans,
pubmed-meshheading:11283132-Mastectomy, Segmental,
pubmed-meshheading:11283132-Matched-Pair Analysis,
pubmed-meshheading:11283132-Michigan,
pubmed-meshheading:11283132-Middle Aged,
pubmed-meshheading:11283132-Prospective Studies,
pubmed-meshheading:11283132-Survival Rate,
pubmed-meshheading:11283132-Time Factors
|
pubmed:year |
2001
|
pubmed:articleTitle |
Accelerated treatment of breast cancer.
|
pubmed:affiliation |
Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA. fvicini@beaumont.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Review
|